ClinConnect ClinConnect Logo
Search / Trial NCT06899880

Perfusion Parameters and Outcome During a Standardized Deresuscitation Strategy with Net Ultrafiltration: a Retrospective Cohort Study.

Launched by HOSPICES CIVILS DE LYON · Mar 21, 2025

Trial Information

Current as of April 23, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years old
  • Acute kidney injury requiring continuous renal replacement therapy
  • Standardized deresuscitation following a routine care protocol
  • Exclusion Criteria:
  • Chronic hemodialysis
  • Advanced directives to withhold or withdraw life-sustaining treatment,
  • Patient's opposition to the use of his/her personal health data

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

France, Bron, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported